Consensus InBody Co.,Ltd

Equities

A041830

KR7041830001

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-25 pm EDT			5-day change	1st Jan Change
26,050 ^KRW	-1.33%		-1.51%	+2.76%

2023	InBody Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	InBody Releases BPBIO 220 and BPBIO 250	CI

Evolution of the average Target Price on InBody Co.,Ltd

Price target over the last 5 years

History of analyst recommendation changes

7ab6e3f78708056c7c2a53e.VlhByvRZM5C1NBrpsibU8ofz4RaQGt-Z7PuarzIDjns.PQIt_MAIQ_aBWmuu-BGbvvOho0_3SrSsoZTY4WJo_R0uO3iTwz5ipuYNdQ~f8a1dec44f18c12f79ae2b9fe32f9764

Analyst Recommendations on InBody Co.,Ltd

Orangetheory® Fitness Partnership with Inbody to Provide Members Body Composition and Heart Rate Analytics

22-01-11

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

26,050 KRW

Average target price

38,000 KRW

Spread / Average Target

+45.87%

High Price Target

39,000 KRW

Spread / Highest target

+49.71%

Low Price Target

37,000 KRW

Spread / Lowest Target

+42.03%

Consensus detail

Consensus revision (last 18 months)

Ratings for InBody Co.,Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar